146 related articles for article (PubMed ID: 26648743)
1. The association between osteopontin and survival in non-small-cell lung cancer patients: a meta-analysis of 13 cohorts.
Wang Y; Yang J; Liu H; Bi JR; Liu Y; Chen YY; Cao JY; Lu YJ
Onco Targets Ther; 2015; 8():3513-21. PubMed ID: 26648743
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and clinicopathological value of osteopontin expression in non-small cell lung cancer: a meta-analysis and systematic review.
Song Y; Li H; Jiang Q; Wu L
Biomarkers; 2024 Mar; 29(2):105-113. PubMed ID: 38376506
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of osteopontin expression in non-small-cell lung cancer: A meta-analysis.
Zou XL; Wang C; Liu KE; Nie W; Ding ZY
Mol Clin Oncol; 2015 May; 3(3):633-638. PubMed ID: 26137280
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of osteopontin expression in gastric cancer: a meta-analysis.
Gu X; Gao XS; Ma M; Qin S; Qi X; Li X; Sun S; Yu H; Wang W; Zhou D
Oncotarget; 2016 Oct; 7(43):69666-69673. PubMed ID: 27626167
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of osteopontin in patients with non-small cell lung cancer: results from a meta-analysis.
Liu Y; Gu X; Lin Q; Tian T; Shao L; Yuan C; Zhang B; Fan K
Int J Clin Exp Med; 2015; 8(8):12765-73. PubMed ID: 26550190
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of osteopontin in hepatocellular carcinoma: a meta-analysis.
Zhang CH; Xu GL; Jia WD; Ge YS; Li JS; Ma JL; Ren WH
Int J Cancer; 2012 Jun; 130(11):2685-92. PubMed ID: 21780114
[TBL] [Abstract][Full Text] [Related]
7. Increased osteopontin protein expression may be correlated with poor prognosis in non-small-cell lung cancer: A meta analysis.
Shi SM; Su ZB; Zhao JJ; Yu DJ; Tu JW; Zhu JQ; Zhao JP; Sheng L; Wang SB; Sheng YJ; Chen HJ; Tian JH; Zhang Y; Wang J
J Cancer Res Ther; 2016; 12(1):277-82. PubMed ID: 27072251
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Values of Vimentin Expression and Its Clinicopathological Significance in Non-Small Cell Lung Cancer: A Meta-Analysis of Observational Studies with 4118 Cases.
Ye Z; Zhang X; Luo Y; Li S; Huang L; Li Z; Li P; Chen G
PLoS One; 2016; 11(9):e0163162. PubMed ID: 27657690
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer.
Rouanne M; Adam J; Goubar A; Robin A; Ohana C; Louvet E; Cormier J; Mercier O; Dorfmüller P; Fattal S; de Montpreville VT; Lebret T; Dartevelle P; Fadel E; Besse B; Olaussen KA; Auclair C; Soria JC
BMC Cancer; 2016 Jul; 16():483. PubMed ID: 27422280
[TBL] [Abstract][Full Text] [Related]
10. Expression of CXCR4 and non-small cell lung cancer prognosis: a meta-analysis.
Liu K; Bao C; Yao N; Miao C; Varlotto J; Sun Q; Sun X
Int J Clin Exp Med; 2015; 8(5):7435-45. PubMed ID: 26221287
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of the prognostic and diagnostic significance of serum/plasma osteopontin in hepatocellular carcinoma.
Cheng J; Wang W; Sun C; Li M; Wang B; Lv Y
J Clin Gastroenterol; 2014 Oct; 48(9):806-14. PubMed ID: 24247813
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of the co-detection of the urokinase plasminogen activator system and osteopontin in patients with non-small-cell lung cancer undergoing radiotherapy and correlation with gross tumor volume.
Ostheimer C; Evers C; Bache M; Reese T; Vordermark D
Strahlenther Onkol; 2018 Jun; 194(6):539-551. PubMed ID: 29340706
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Plasma Fibrinogen in Lung Cancer Patients: A Meta-Analysis.
Zhong H; Qian Y; Fang S; Wang Y; Tang Y; Gu W
J Cancer; 2018; 9(21):3904-3911. PubMed ID: 30410594
[No Abstract] [Full Text] [Related]
14. Osteopontin is a novel prognostic biomarker in early-stage non-small cell lung cancer after surgical resection.
Yan CH; Lv M; Li H; Song X; Yan F; Cao S; Ren X
J Cancer Res Clin Oncol; 2015 Aug; 141(8):1371-8. PubMed ID: 25555465
[TBL] [Abstract][Full Text] [Related]
15. Clinical and prognostic significance of OPN and VEGF expression in patients with non-small-cell lung cancer.
Lin Q; Guo L; Lin G; Chen Z; Chen T; Lin J; Zhang B; Gu X
Cancer Epidemiol; 2015 Aug; 39(4):539-44. PubMed ID: 26123318
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of osteopontin expression in breast cancer: A meta-analysis.
Xu YY; Zhang YY; Lu WF; Mi YJ; Chen YQ
Mol Clin Oncol; 2015 Mar; 3(2):357-362. PubMed ID: 25798267
[TBL] [Abstract][Full Text] [Related]
17. Elevated circulating level of osteopontin is associated with advanced disease state of non-small cell lung cancer.
Chang YS; Kim HJ; Chang J; Ahn CM; Kim SK; Kim SK
Lung Cancer; 2007 Sep; 57(3):373-80. PubMed ID: 17513004
[TBL] [Abstract][Full Text] [Related]
18. Association of osteopontin with specific prognostic factors and survival in adjuvant breast cancer trials of the Hellenic Cooperative Oncology Group.
Psyrri A; Kalogeras KT; Wirtz RM; Kouvatseas G; Karayannopoulou G; Goussia A; Zagouri F; Veltrup E; Timotheadou E; Gogas H; Koutras A; Lazaridis G; Christodoulou C; Pentheroudakis G; Economopoulou P; Laskarakis A; Arapantoni-Dadioti P; Batistatou A; Sotiropoulou M; Aravantinos G; Papakostas P; Kosmidis P; Pectasides D; Fountzilas G
J Transl Med; 2017 Feb; 15(1):30. PubMed ID: 28193231
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin expression is associated with platinum-based chemotherapy response and prognosis of patients with advanced non small cell lung cancer.
Zhang T; Zhang DM; Zhao D; Hou XM; Yang TN
J BUON; 2014; 19(3):742-8. PubMed ID: 25261661
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of TAZ expression in various cancers: a meta-analysis.
Feng J; Ren P; Gou J; Li Z
Onco Targets Ther; 2016; 9():5235-44. PubMed ID: 27601916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
